TTM
$12.14B
YoY change
+19.4%
5Y CAGR
+8.6%
Peak year (2025)
$12.94B
Cumulative EBITDA
$142.61B
EBITDA history chart for Accenture (ACN) from 2001 to 2025
Latest: $12.94B
EBITDA growth chart for Accenture (ACN) from 2001 to 2025
Latest: +19.4%
EBITDA history table for Accenture (ACN) from 2001 to 2025
| 2025 | $12.94B | +19.4% | +$2.10B | ||
| 2024 | $10.84B | +5.7% | +$587.82M | ||
| 2023 | $10.25B | -0.2% | −$25.66M | ||
| 2022 | $10.27B | +5.8% | +$562.28M | ||
| 2021 | $9.71B | +13.2% | +$1.13B | ||
| 2020 | $8.58B | +19.7% | +$1.41B | ||
| 2019 | $7.17B | +6.1% | +$413.11M | ||
| 2018 | $6.75B | +24.3% | +$1.32B | ||
| 2017 | $5.43B | -14.4% | −$915.52M | ||
| 2016 | $6.35B | +25.2% | +$1.28B | ||
| 2015 | $5.07B | +2.7% | +$134.97M | ||
| 2014 | $4.94B | -0.2% | −$10.29M | ||
| 2013 | $4.95B | +9.6% | +$433.58M | ||
| 2012 | $4.51B | +11.7% | +$472.50M | ||
| 2011 | $4.04B | +18.7% | +$636.54M | ||
| 2010 | $3.40B | +6.7% | +$213.29M | ||
| 2009 | $3.19B | -11.9% | −$431.44M | ||
| 2008 | $3.62B | +22.2% | +$658.40M | ||
| 2007 | $2.96B | +40.2% | +$849.78M | ||
| 2006 | $2.11B | -8.3% | −$190.35M | ||
| 2005 | $2.30B | +12.7% | +$259.46M | ||
| 2004 | $2.04B | +9.3% | +$173.56M | ||
| 2003 | $1.87B | +33.5% | +$469.25M | ||
| 2002 | $1.40B | -28.4% | −$556.66M | ||
| 2001 | $1.96B | — | — |
- 2025$12.94B+19.4%
- 2024$10.84B+5.7%
- 2023$10.25B-0.2%
- 2022$10.27B+5.8%
- 2021$9.71B+13.2%
- 2020$8.58B+19.7%
- 2019$7.17B+6.1%
- 2018$6.75B+24.3%
- 2017$5.43B-14.4%
- 2016$6.35B+25.2%
- 2015$5.07B+2.7%
- 2014$4.94B-0.2%
- 2013$4.95B+9.6%
- 2012$4.51B+11.7%
- 2011$4.04B+18.7%
- 2010$3.40B+6.7%
- 2009$3.19B-11.9%
- 2008$3.62B+22.2%
- 2007$2.96B+40.2%
- 2006$2.11B-8.3%
- 2005$2.30B+12.7%
- 2004$2.04B+9.3%
- 2003$1.87B+33.5%
- 2002$1.40B-28.4%
- 2001$1.96B—
EBITDA values are taken from Accenture's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Accenture (ACN)
According to Accenture's latest reported financial statements, the company's current EBITDA (TTM) is $12.14B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Accenture (ACN) reported EBITDA of $12.94B – grew 19.4% year-over-year.
Accenture EBITDA has grown for 2 consecutive years, with a +8.6% compound annual growth rate over 2020–2025 (5 years).
2025 marks the peak EBITDA at $12.94B, with the historical low of $1.40B recorded in 2002.
Accenture EBITDA by Year
Accenture EBITDA 2025: $12.94B
Accenture EBITDA in 2025 was $12.94B, grew 19.4% from 2024. This figure represents the highest annual value in the available history.
Accenture EBITDA 2024: $10.84B
2024's EBITDA for Accenture came in at $10.84B, grew 5.7% from 2023.
Accenture EBITDA 2023: $10.25B
Accenture posted EBITDA of $10.25B in 2023, edged down 0.2% below 2022.
Accenture EBITDA 2022: $10.27B
In 2022, Accenture reported EBITDA of $10.27B, grew 5.8% from 2021.
Accenture EBITDA 2021: $9.71B
Accenture EBITDA in 2021 was $9.71B.
See more financial history for Accenture (ACN).
Sector peers by EBITDA
Technology peers of Accenture (ACN), ranked by their latest EBITDA
| $160.16B | |
| $144.55B | |
| $144.43B | |
| $88.75B | |
| $34.71B | |
| $18.49B | |
| $14.61B | |
| $7.28B |
- $160.16B
- $144.55B
- $144.43B
- $88.75B
- $34.71B
- $18.49B
- $14.61B
- $7.28B
Frequently asked questions
Accenture (ACN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation